H. Lundbeck A
ISIN: DK0061804697 | Ticker: HLUN | LEI: 5493006R4KC2OI5D3470
Country: Denmark
Lundbeck is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research and today our products are available in more than 100 countries. We are tirelessly dedicated to restoring brain health, so every person can be their best.
Research into the brain costs more, takes longer and fails at a higher rate than most other medical research. But with brain disorders sharply on the increase, it’s more important than ever. We are one of the only global pharmaceutical companies solely focused on the brain, and our research programs tackle some of the most complex challenges in neuroscience. Our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options.
1915
Served areaWorldwide
Headcount5,300
HeadquartersOttiliavej 9, 2500 Valby – Denmark
| Line item in (dkk) | 01.01.2020 | 01.04.2020 | 01.07.2020 | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 | 01.10.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | N/A | 37,036,000,000.00 | 37,200,000,000.00 | N/A | 36,029,000,000.00 | 34,465,000,000.00 | 34,036,000,000.00 | 35,119,000,000.00 | 34,653,000,000.00 | 35,071,000,000.00 | 37,275,000,000.00 | 39,305,000,000.00 | 37,452,000,000.00 | 36,624,000,000.00 | 37,242,000,000.00 | 37,672,000,000.00 |
| Noncurrent Assets | N/A | 28,375,000,000.00 | 27,792,000,000.00 | 26,776,000,000.00 | 25,924,000,000.00 | 26,358,000,000.00 | 25,891,000,000.00 | 25,987,000,000.00 | 26,041,000,000.00 | 26,027,000,000.00 | 26,726,000,000.00 | 27,271,000,000.00 | 26,040,000,000.00 | 25,490,000,000.00 | 25,092,000,000.00 | 25,024,000,000.00 |
| Property Plant And Equipment | N/A | 2,639,000,000.00 | 2,637,000,000.00 | 2,652,000,000.00 | 2,733,000,000.00 | 2,758,000,000.00 | 2,752,000,000.00 | 2,789,000,000.00 | 2,423,000,000.00 | 2,893,000,000.00 | 2,901,000,000.00 | 2,920,000,000.00 | 2,515,000,000.00 | 2,502,000,000.00 | 2,483,000,000.00 | 2,470,000,000.00 |
| Land And Buildings | N/A | N/A | N/A | N/A | 1,219,000,000.00 | N/A | N/A | N/A | 1,179,000,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fixtures And Fittings | N/A | N/A | N/A | N/A | 122,000,000.00 | N/A | N/A | N/A | 165,000,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | 4,845,000,000.00 | N/A | N/A | N/A | 5,377,000,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets Under Development | N/A | N/A | N/A | N/A | 171,000,000.00 | N/A | N/A | N/A | 133,000,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Noncurrent Receivables | N/A | 112,000,000.00 | 103,000,000.00 | 105,000,000.00 | 104,000,000.00 | 119,000,000.00 | 124,000,000.00 | 131,000,000.00 | 134,000,000.00 | 160,000,000.00 | 159,000,000.00 | 154,000,000.00 | 195,000,000.00 | 203,000,000.00 | 215,000,000.00 | 228,000,000.00 |
| Deferred Tax Assets | N/A | 137,000,000.00 | 225,000,000.00 | 260,000,000.00 | 233,000,000.00 | 266,000,000.00 | 271,000,000.00 | 278,000,000.00 | 193,000,000.00 | 206,000,000.00 | 222,000,000.00 | 233,000,000.00 | 230,000,000.00 | 235,000,000.00 | 227,000,000.00 | 232,000,000.00 |
| Other Noncurrent Financial Assets | N/A | 55,000,000.00 | 167,000,000.00 | 127,000,000.00 | 116,000,000.00 | 82,000,000.00 | 77,000,000.00 | 64,000,000.00 | 57,000,000.00 | 54,000,000.00 | 212,000,000.00 | 199,000,000.00 | 173,000,000.00 | 146,000,000.00 | 137,000,000.00 | 119,000,000.00 |
| Current Assets | N/A | 8,661,000,000.00 | 9,408,000,000.00 | N/A | 10,105,000,000.00 | 8,107,000,000.00 | 8,145,000,000.00 | 9,132,000,000.00 | 8,612,000,000.00 | 9,044,000,000.00 | 10,549,000,000.00 | 12,034,000,000.00 | 11,412,000,000.00 | 11,134,000,000.00 | 12,150,000,000.00 | 12,648,000,000.00 |
| Inventories | N/A | 2,349,000,000.00 | 2,433,000,000.00 | 2,205,000,000.00 | 2,163,000,000.00 | 2,582,000,000.00 | 2,596,000,000.00 | 2,756,000,000.00 | 3,031,000,000.00 | 3,518,000,000.00 | 3,709,000,000.00 | 3,984,000,000.00 | 4,046,000,000.00 | 4,076,000,000.00 | 4,276,000,000.00 | 4,386,000,000.00 |
| Trade And Other Current Receivables | N/A | 4,025,000,000.00 | 3,734,000,000.00 | 3,957,000,000.00 | 4,018,000,000.00 | 3,864,000,000.00 | 3,858,000,000.00 | 3,872,000,000.00 | 3,302,000,000.00 | 3,912,000,000.00 | 4,542,000,000.00 | 4,644,000,000.00 | 3,818,000,000.00 | 4,176,000,000.00 | 4,211,000,000.00 | 4,014,000,000.00 |
| Current Trade Receivables | N/A | N/A | N/A | N/A | 2,553,000,000.00 | N/A | N/A | N/A | 2,459,000,000.00 | N/A | N/A | N/A | 2,709,000,000.00 | N/A | N/A | N/A |
| Current Prepayments | N/A | N/A | N/A | N/A | 380,000,000.00 | N/A | N/A | N/A | 371,000,000.00 | N/A | N/A | N/A | 255,000,000.00 | N/A | N/A | N/A |
| Other Current Receivables | N/A | N/A | N/A | N/A | 868,000,000.00 | N/A | N/A | N/A | 289,000,000.00 | N/A | N/A | N/A | 756,000,000.00 | N/A | N/A | N/A |
| Current Tax Assets Current | N/A | N/A | N/A | N/A | 217,000,000.00 | N/A | N/A | N/A | 183,000,000.00 | N/A | N/A | N/A | 98,000,000.00 | N/A | N/A | N/A |
| Cash and cash equivalents | 3,008,000,000.00 | 2,283,000,000.00 | 3,241,000,000.00 | N/A | 3,924,000,000.00 | 1,661,000,000.00 | 1,691,000,000.00 | 2,504,000,000.00 | 2,279,000,000.00 | 1,614,000,000.00 | 2,298,000,000.00 | 3,406,000,000.00 | 3,548,000,000.00 | 2,882,000,000.00 | 3,663,000,000.00 | 4,248,000,000.00 |
| Equity And Liabilities | N/A | 37,036,000,000.00 | 37,200,000,000.00 | N/A | 36,029,000,000.00 | 34,465,000,000.00 | 34,036,000,000.00 | 35,119,000,000.00 | 34,653,000,000.00 | 35,071,000,000.00 | 37,275,000,000.00 | 39,305,000,000.00 | 37,452,000,000.00 | 36,624,000,000.00 | 37,242,000,000.00 | 37,672,000,000.00 |
| Equity | 16,782,000,000.00 | 16,243,000,000.00 | 16,602,000,000.00 | N/A | 16,973,000,000.00 | 17,223,000,000.00 | 17,540,000,000.00 | 18,083,000,000.00 | 18,279,000,000.00 | 18,446,000,000.00 | 19,596,000,000.00 | 20,919,000,000.00 | 20,779,000,000.00 | 20,980,000,000.00 | 21,572,000,000.00 | 22,305,000,000.00 |
| Issued Capital | N/A | 996,000,000.00 | 996,000,000.00 | N/A | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 | 996,000,000.00 |
| Retained Earnings | N/A | 14,266,000,000.00 | 14,768,000,000.00 | N/A | 15,748,000,000.00 | 15,896,000,000.00 | 16,236,000,000.00 | 16,567,000,000.00 | 16,571,000,000.00 | 16,549,000,000.00 | 17,059,000,000.00 | 17,754,000,000.00 | 18,189,000,000.00 | 18,458,000,000.00 | 19,069,000,000.00 | 19,753,000,000.00 |
| Liabilities | N/A | 20,793,000,000.00 | 20,598,000,000.00 | N/A | 19,056,000,000.00 | 17,242,000,000.00 | 16,496,000,000.00 | 17,036,000,000.00 | 16,374,000,000.00 | 16,625,000,000.00 | 17,679,000,000.00 | 18,386,000,000.00 | 16,673,000,000.00 | 15,644,000,000.00 | 15,670,000,000.00 | 15,367,000,000.00 |
| Noncurrent Liabilities | N/A | 12,928,000,000.00 | 12,536,000,000.00 | N/A | 9,044,000,000.00 | 9,278,000,000.00 | 8,058,000,000.00 | 7,952,000,000.00 | 7,556,000,000.00 | 8,795,000,000.00 | 9,176,000,000.00 | 9,250,000,000.00 | 8,474,000,000.00 | 8,198,000,000.00 | 7,980,000,000.00 | 7,329,000,000.00 |
| Noncurrent Provisions | N/A | 262,000,000.00 | 219,000,000.00 | N/A | 139,000,000.00 | 142,000,000.00 | 89,000,000.00 | 81,000,000.00 | 92,000,000.00 | 126,000,000.00 | 130,000,000.00 | 149,000,000.00 | 190,000,000.00 | 200,000,000.00 | 216,000,000.00 | 307,000,000.00 |
| Other Noncurrent Payables | N/A | 1,247,000,000.00 | 1,233,000,000.00 | N/A | 1,190,000,000.00 | 1,574,000,000.00 | 439,000,000.00 | 474,000,000.00 | 492,000,000.00 | 514,000,000.00 | 549,000,000.00 | 567,000,000.00 | 428,000,000.00 | 418,000,000.00 | 421,000,000.00 | 433,000,000.00 |
| Deferred Tax Liabilities | N/A | 1,564,000,000.00 | 1,637,000,000.00 | N/A | 1,614,000,000.00 | 1,522,000,000.00 | 1,532,000,000.00 | 1,615,000,000.00 | 1,448,000,000.00 | 1,482,000,000.00 | 1,860,000,000.00 | 2,057,000,000.00 | 2,152,000,000.00 | 2,233,000,000.00 | 2,277,000,000.00 | 2,316,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | 295,000,000.00 | 291,000,000.00 | N/A | 288,000,000.00 | 288,000,000.00 | 288,000,000.00 | 284,000,000.00 | 288,000,000.00 | 286,000,000.00 | 285,000,000.00 | 285,000,000.00 | 213,000,000.00 | 205,000,000.00 | 205,000,000.00 | 207,000,000.00 |
| Longterm Borrowings | N/A | 9,143,000,000.00 | 8,722,000,000.00 | N/A | 5,397,000,000.00 | 5,314,000,000.00 | 5,292,000,000.00 | 5,080,000,000.00 | 4,783,000,000.00 | 5,945,000,000.00 | 5,921,000,000.00 | 5,762,000,000.00 | 5,096,000,000.00 | 4,772,000,000.00 | 4,499,000,000.00 | 3,715,000,000.00 |
| Current Liabilities | N/A | 7,865,000,000.00 | 8,062,000,000.00 | N/A | 10,012,000,000.00 | 7,964,000,000.00 | 8,438,000,000.00 | 9,084,000,000.00 | 8,818,000,000.00 | 7,830,000,000.00 | 8,503,000,000.00 | 9,136,000,000.00 | 8,199,000,000.00 | 7,446,000,000.00 | 7,690,000,000.00 | 8,038,000,000.00 |
| Current Provisions | N/A | 1,908,000,000.00 | 1,790,000,000.00 | N/A | 1,672,000,000.00 | 1,485,000,000.00 | 1,266,000,000.00 | 1,269,000,000.00 | 1,405,000,000.00 | 1,359,000,000.00 | 1,314,000,000.00 | 1,386,000,000.00 | 1,132,000,000.00 | 1,124,000,000.00 | 1,180,000,000.00 | 1,044,000,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 3,631,000,000.00 | 3,592,000,000.00 | N/A | 3,740,000,000.00 | 3,667,000,000.00 | 3,686,000,000.00 | 4,271,000,000.00 | 3,914,000,000.00 | 4,138,000,000.00 | 4,452,000,000.00 | 4,603,000,000.00 | 4,251,000,000.00 | 3,787,000,000.00 | 4,052,000,000.00 | 4,065,000,000.00 |
| Other Current Payables | N/A | 1,537,000,000.00 | 1,803,000,000.00 | N/A | 1,846,000,000.00 | 1,497,000,000.00 | 2,714,000,000.00 | 2,883,000,000.00 | 2,893,000,000.00 | 1,720,000,000.00 | 2,123,000,000.00 | 2,505,000,000.00 | 2,192,000,000.00 | 1,792,000,000.00 | 1,746,000,000.00 | 2,156,000,000.00 |
| Current Tax Liabilities Current | N/A | 712,000,000.00 | 801,000,000.00 | N/A | 675,000,000.00 | 834,000,000.00 | 693,000,000.00 | 581,000,000.00 | 519,000,000.00 | 528,000,000.00 | 526,000,000.00 | 553,000,000.00 | 535,000,000.00 | 660,000,000.00 | 630,000,000.00 | 692,000,000.00 |
| Current Recognised Liabilities Defined Benefit Plan | N/A | 0.00 | 0.00 | N/A | 2,000,000.00 | 2,000,000.00 | 2,000,000.00 | 2,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 | 1,000,000.00 |
| Line item in (dkk) | 01.01.2020/ 01.04.2020 |
01.01.2020/ 01.07.2020 |
01.01.2020/ 01.10.2020 |
01.01.2020/ 01.01.2021 |
01.04.2020/ 01.07.2020 |
01.07.2020/ 01.10.2020 |
01.01.2021/ 01.04.2021 |
01.01.2021/ 01.07.2021 |
01.01.2021/ 01.10.2021 |
01.01.2021/ 01.01.2022 |
01.04.2021/ 01.07.2021 |
01.07.2021/ 01.10.2021 |
01.01.2022/ 01.04.2022 |
01.01.2022/ 01.07.2022 |
01.01.2022/ 01.10.2022 |
01.01.2022/ 01.01.2023 |
01.04.2022/ 01.07.2022 |
01.07.2022/ 01.10.2022 |
01.01.2023/ 01.04.2023 |
01.01.2023/ 01.07.2023 |
01.01.2023/ 01.10.2023 |
01.04.2023/ 01.07.2023 |
01.07.2023/ 01.10.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,564,000,000.00 | 8,934,000,000.00 | 13,397,000,000.00 | 17,672,000,000.00 | 4,370,000,000.00 | 4,463,000,000.00 | 4,273,000,000.00 | 8,233,000,000.00 | 12,246,000,000.00 | 16,299,000,000.00 | 3,960,000,000.00 | 4,013,000,000.00 | 4,372,000,000.00 | 8,847,000,000.00 | 13,566,000,000.00 | 18,246,000,000.00 | 4,475,000,000.00 | 4,719,000,000.00 | 5,044,000,000.00 | 9,982,000,000.00 | 14,934,000,000.00 | 4,938,000,000.00 | 4,952,000,000.00 |
| Profit Loss From Operating Activities | 263,000,000.00 | 934,000,000.00 | 1,559,000,000.00 | 1,990,000,000.00 | 671,000,000.00 | 625,000,000.00 | 882,000,000.00 | 1,478,000,000.00 | 2,004,000,000.00 | 2,010,000,000.00 | 596,000,000.00 | 526,000,000.00 | 875,000,000.00 | 1,497,000,000.00 | 2,449,000,000.00 | 2,852,000,000.00 | 622,000,000.00 | 952,000,000.00 | 1,233,000,000.00 | 2,073,000,000.00 | 2,964,000,000.00 | 840,000,000.00 | 891,000,000.00 |
| Finance Income | N/A | N/A | N/A | 277,000,000.00 | N/A | N/A | N/A | N/A | N/A | 14,000,000.00 | N/A | N/A | N/A | N/A | N/A | 124,000,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Finance Costs | N/A | N/A | N/A | 361,000,000.00 | N/A | N/A | N/A | N/A | N/A | 443,000,000.00 | N/A | N/A | N/A | N/A | N/A | 502,000,000.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Profit Loss Before Tax | 166,000,000.00 | 934,000,000.00 | 1,487,000,000.00 | 1,906,000,000.00 | 768,000,000.00 | 553,000,000.00 | 797,000,000.00 | 1,281,000,000.00 | 1,693,000,000.00 | 1,581,000,000.00 | 484,000,000.00 | 412,000,000.00 | 528,000,000.00 | 1,175,000,000.00 | 2,057,000,000.00 | 2,474,000,000.00 | 647,000,000.00 | 882,000,000.00 | 1,150,000,000.00 | 1,935,000,000.00 | 2,818,000,000.00 | 785,000,000.00 | 883,000,000.00 |
| Income Tax Expense Continuing Operations | 74,000,000.00 | 319,000,000.00 | 459,000,000.00 | 325,000,000.00 | 245,000,000.00 | 140,000,000.00 | 176,000,000.00 | 282,000,000.00 | 373,000,000.00 | 263,000,000.00 | 106,000,000.00 | 91,000,000.00 | 116,000,000.00 | 258,000,000.00 | 452,000,000.00 | 558,000,000.00 | 142,000,000.00 | 194,000,000.00 | 270,000,000.00 | 455,000,000.00 | 662,000,000.00 | 185,000,000.00 | 207,000,000.00 |
| Profit (loss) | 92,000,000.00 | 615,000,000.00 | 1,028,000,000.00 | 1,581,000,000.00 | 523,000,000.00 | 413,000,000.00 | 621,000,000.00 | 999,000,000.00 | 1,320,000,000.00 | 1,318,000,000.00 | 378,000,000.00 | 321,000,000.00 | 412,000,000.00 | 917,000,000.00 | 1,605,000,000.00 | 1,916,000,000.00 | 505,000,000.00 | 688,000,000.00 | 880,000,000.00 | 1,480,000,000.00 | 2,156,000,000.00 | 600,000,000.00 | 676,000,000.00 |
| Line item in (dkk) | 01.01.2020 | 01.04.2020 | 01.07.2020 | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 | 01.10.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) | N/A | 92,000,000.00 | 523,000,000.00 | 413,000,000.00 | 1,581,000,000.00 | 621,000,000.00 | 378,000,000.00 | 321,000,000.00 | 1,318,000,000.00 | 412,000,000.00 | 505,000,000.00 | 688,000,000.00 | 1,916,000,000.00 | 880,000,000.00 | 600,000,000.00 | 676,000,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | N/A | N/A | N/A | -265,000,000.00 | N/A | N/A | N/A | -828,000,000.00 | N/A | N/A | N/A | -979,000,000.00 | N/A | N/A | N/A |
| Adjustments For Provisions | N/A | N/A | N/A | N/A | -307,000,000.00 | N/A | N/A | N/A | -447,000,000.00 | N/A | N/A | N/A | -244,000,000.00 | N/A | N/A | N/A |
| Adjustments For Sharebased Payments | N/A | N/A | N/A | N/A | 30,000,000.00 | N/A | N/A | N/A | 37,000,000.00 | N/A | N/A | N/A | 30,000,000.00 | N/A | N/A | N/A |
| Other Adjustments For Noncash Items | N/A | 1,118,000,000.00 | 309,000,000.00 | N/A | 2,477,000,000.00 | 213,000,000.00 | 106,000,000.00 | 317,000,000.00 | 1,148,000,000.00 | 348,000,000.00 | 288,000,000.00 | 474,000,000.00 | N/A | 623,000,000.00 | 745,000,000.00 | 520,000,000.00 |
| Other Adjustments To Reconcile Profit Loss | N/A | N/A | N/A | N/A | -39,000,000.00 | N/A | N/A | N/A | -152,000,000.00 | N/A | N/A | N/A | 18,000,000.00 | N/A | N/A | N/A |
| Cash Flows From Used In Operations | N/A | 329,000,000.00 | 1,517,000,000.00 | N/A | 4,449,000,000.00 | 180,000,000.00 | 889,000,000.00 | 1,357,000,000.00 | 2,853,000,000.00 | 344,000,000.00 | 973,000,000.00 | 1,551,000,000.00 | 4,062,000,000.00 | 495,000,000.00 | 1,465,000,000.00 | 1,581,000,000.00 |
| Cash Flows From Used In Operating Activities | N/A | 188,000,000.00 | 1,407,000,000.00 | N/A | 3,837,000,000.00 | 108,000,000.00 | 562,000,000.00 | 1,219,000,000.00 | 2,272,000,000.00 | -205,000,000.00 | 916,000,000.00 | 1,521,000,000.00 | 3,519,000,000.00 | 378,000,000.00 | 1,271,000,000.00 | 1,490,000,000.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | N/A | N/A | N/A | 1,000,000.00 | N/A | N/A | N/A | 2,000,000.00 | N/A | N/A | N/A | 4,000,000.00 | N/A | N/A | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | N/A | N/A | N/A | 364,000,000.00 | N/A | N/A | N/A | 410,000,000.00 | N/A | N/A | N/A | 371,000,000.00 | N/A | N/A | N/A |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | N/A | N/A | N/A | 114,000,000.00 | N/A | N/A | N/A | 202,000,000.00 | N/A | N/A | N/A | 449,000,000.00 | N/A | N/A | N/A |
| Cash Flows From Used In Investing Activities | N/A | -68,000,000.00 | -48,000,000.00 | N/A | -467,000,000.00 | -84,000,000.00 | -110,000,000.00 | -138,000,000.00 | -610,000,000.00 | -1,163,000,000.00 | -64,000,000.00 | -133,000,000.00 | -1,892,000,000.00 | -77,000,000.00 | -188,000,000.00 | -97,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | N/A | N/A | N/A | 29,000,000.00 | N/A | N/A | N/A | 34,000,000.00 | N/A | N/A | N/A | 45,000,000.00 | N/A | N/A | N/A |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 0.00 | 0.00 | N/A | 3,701,000,000.00 | 400,000,000.00 | 0.00 | 0.00 | 400,000,000.00 | 1,234,000,000.00 | 0.00 | 0.00 | 1,234,000,000.00 | 0.00 | 0.00 | 0.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 0.00 | 341,000,000.00 | N/A | 5,169,000,000.00 | 2,152,000,000.00 | 400,000,000.00 | 250,000,000.00 | 3,123,000,000.00 | 98,000,000.00 | 168,000,000.00 | 286,000,000.00 | 1,086,000,000.00 | 314,000,000.00 | 274,000,000.00 | 789,000,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | N/A | N/A | N/A | 83,000,000.00 | N/A | N/A | N/A | 82,000,000.00 | N/A | N/A | N/A | 93,000,000.00 | N/A | N/A | N/A |
| Dividends Paid Classified As Financing Activities | N/A | 815,000,000.00 | 0.00 | N/A | 815,000,000.00 | 497,000,000.00 | 0.00 | 0.00 | 497,000,000.00 | 397,000,000.00 | 0.00 | 0.00 | 397,000,000.00 | 576,000,000.00 | 0.00 | 0.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | N/A | -22,000,000.00 | -50,000,000.00 | N/A | -112,000,000.00 | -54,000,000.00 | -20,000,000.00 | -22,000,000.00 | -116,000,000.00 | -70,000,000.00 | -21,000,000.00 | -25,000,000.00 | N/A | -65,000,000.00 | -21,000,000.00 | -25,000,000.00 |
| Cash Flows From Used In Financing Activities | N/A | -836,000,000.00 | -391,000,000.00 | N/A | -2,394,000,000.00 | -2,303,000,000.00 | -420,000,000.00 | -272,000,000.00 | -3,336,000,000.00 | 669,000,000.00 | -189,000,000.00 | -311,000,000.00 | -387,000,000.00 | -955,000,000.00 | -295,000,000.00 | -814,000,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -716,000,000.00 | 968,000,000.00 | N/A | 976,000,000.00 | -2,279,000,000.00 | 32,000,000.00 | 809,000,000.00 | -1,674,000,000.00 | -699,000,000.00 | 663,000,000.00 | 1,077,000,000.00 | 1,240,000,000.00 | -654,000,000.00 | 788,000,000.00 | 579,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -9,000,000.00 | -10,000,000.00 | N/A | -60,000,000.00 | 16,000,000.00 | -2,000,000.00 | 4,000,000.00 | 29,000,000.00 | 34,000,000.00 | 21,000,000.00 | 31,000,000.00 | 29,000,000.00 | -12,000,000.00 | -7,000,000.00 | 6,000,000.00 |
| Cash and cash equivalents | 3,008,000,000.00 | 2,283,000,000.00 | 3,241,000,000.00 | N/A | 3,924,000,000.00 | 1,661,000,000.00 | 1,691,000,000.00 | 2,504,000,000.00 | 2,279,000,000.00 | 1,614,000,000.00 | 2,298,000,000.00 | 3,406,000,000.00 | 3,548,000,000.00 | 2,882,000,000.00 | 3,663,000,000.00 | 4,248,000,000.00 |
Please note that some sums might not add up.
DK0061804697
LEI5493006R4KC2OI5D3470
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.